Studies have reported that CD44s were more closely related to HER-2 or basal cell subtypes in molecular typing of breast cancer [27] and were significantly associated with tumor aggressiveness and poor prognosis in breast cancer with axillary lymph node metastases [28]. This evidence concerns the gene ERBB2 and breast carcinoma.